Aspiriant LLC’s iShares MSCI Global Min Vol Factor ETF ACWV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $291M | Buy |
2,438,432
+32,332
| +1% | +$3.92M | 8.3% | 4 |
|
|
2025
Q4 | $286M | Sell |
2,406,100
-13,577
| -0.6% | -$1.62M | 8.21% | 4 |
|
|
2025
Q3 | $290M | Buy |
2,419,677
+4,540
| +0.2% | +$539K | 8.87% | 4 |
|
|
2025
Q2 | $286M | Sell |
2,415,137
-34,259
| -1% | -$3.99M | 9.1% | 4 |
|
|
2025
Q1 | $285M | Buy |
2,449,396
+22,856
| +0.9% | +$2.58M | 9.89% | 4 |
|
|
2024
Q4 | $265M | Buy |
2,426,540
+13,103
| +0.5% | +$1.48M | 9.57% | 3 |
|
|
2024
Q3 | $276M | Buy |
2,413,437
+2,734
| +0.1% | +$301K | 10.49% | 1 |
|
|
2024
Q2 | $252M | Sell |
2,410,703
-60,101
| -2% | -$6.25M | 10.28% | 2 |
|
|
2024
Q1 | $260M | Sell |
2,470,804
-147,528
| -6% | -$15.1M | 10.77% | 1 |
|
|
2023
Q4 | $263M | Sell |
2,618,332
-146,061
| -5% | -$14.2M | 11.83% | 2 |
|
|
2023
Q3 | $264M | Sell |
2,764,393
-37,541
| -1% | -$3.67M | 13.5% | 1 |
|
|
2023
Q2 | $275M | Sell |
2,801,934
-37,098
| -1% | -$3.64M | 13.89% | 1 |
|
|
2023
Q1 | $275M | Buy |
2,839,032
+38,608
| +1% | +$3.68M | 14.38% | 1 |
|
|
2022
Q4 | $266M | Sell |
2,800,424
-282,284
| -9% | -$26.5M | 13.56% | 2 |
|
|
2022
Q3 | $273M | Buy |
3,082,708
+2,773
| +0.1% | +$265K | 13.36% | 1 |
|
|
2022
Q2 | $291M | Buy |
3,079,935
+315,033
| +11% | +$31.2M | 14.05% | 1 |
|
|
2022
Q1 | $290M | Buy |
2,764,902
+67,344
| +2% | +$6.95M | 15.93% | 1 |
|
|
2021
Q4 | $292M | Buy |
2,697,558
+3,712
| +0.1% | +$392K | 15.61% | 1 |
|
|
2021
Q3 | $277M | Sell |
2,693,846
-5,110
| -0.2% | -$538K | 16.25% | 1 |
|
|
2021
Q2 | $278M | Buy |
2,698,956
+117,777
| +5% | +$12M | 15.7% | 1 |
|
|
2021
Q1 | $255M | Sell |
2,581,179
-10,183
| -0.4% | -$988K | 16.27% | 1 |
|
|
2020
Q4 | $251M | Sell |
2,591,362
-13,262
| -0.5% | -$1.25M | 17.14% | 1 |
|
|
2020
Q3 | $239M | Buy |
2,604,624
+15,343
| +0.6% | +$1.4M | 18.72% | 1 |
|
|
2020
Q2 | $227M | Buy |
2,589,281
+457,755
| +21% | +$39.6M | 21.06% | 1 |
|
|
2020
Q1 | $171M | Buy |
2,131,526
+122,992
| +6% | +$11.3M | 16.87% | 1 |
|
|
2019
Q4 | $192M | Sell |
2,008,534
-30,013
| -1% | -$2.86M | 17.81% | 1 |
|
|
2019
Q3 | $193M | Buy |
2,038,547
+126,589
| +7% | +$11.8M | 17.3% | 1 |
|
|
2019
Q2 | $176M | Buy |
1,911,958
+74,421
| +4% | +$6.71M | 14.7% | 1 |
|
|
2019
Q1 | $164M | Buy |
1,837,537
+6,129
| +0.3% | +$527K | 13.43% | 1 |
|
|
2018
Q4 | $149M | Buy |
1,831,408
+257,954
| +16% | +$21.8M | 11.28% | 1 |
|
|
2018
Q3 | $138M | Sell |
1,573,454
-30,974
| -2% | -$2.66M | 11.82% | 1 |
|
|
2018
Q2 | $133M | Sell |
1,604,428
-7,422
| -0.5% | -$622K | 11.41% | 1 |
|
|
2018
Q1 | $135M | Buy |
1,611,850
+1,055,354
| +190% | +$89.2M | 11.79% | 1 |
|
|
2017
Q4 | $46.9M | Sell |
556,496
-917,089
| -62% | -$76.3M | 13.77% | 1 |
|
|
2017
Q3 | $120M | Buy |
1,473,585
+123,179
| +9% | +$9.92M | 10.05% | 1 |
|
|
2017
Q2 | $107M | Buy |
1,350,406
+72,083
| +6% | +$5.69M | 9.29% | 1 |
|
|
2017
Q1 | $98.6M | Buy |
1,278,323
+56,898
| +5% | +$4.29M | 8.4% | 2 |
|
|
2016
Q4 | $88.7M | Sell |
1,221,425
-123,284
| -9% | -$9.04M | 8.03% | 3 |
|
|
2016
Q3 | $102M | Buy |
1,344,709
+191,309
| +17% | +$14.7M | 10.2% | 2 |
|
|
2016
Q2 | $88.1M | Buy |
1,153,400
+75,665
| +7% | +$5.6M | 8.32% | 4 |
|
|
2016
Q1 | $79.2M | Buy |
1,077,735
+128,168
| +13% | +$8.87M | 7.56% | 4 |
|
|
2015
Q4 | $65.8M | Buy |
949,567
+340,912
| +56% | +$23.8M | 7.23% | 6 |
|
|
2015
Q3 | $40.8M | Buy |
+608,655
| New | +$42.1M | 3.39% | 10 |
|
Other funds holding ACWV
Aspiriant LLC's ACWV Position: Q1 2026 in Review
Aspiriant LLC increased its iShares MSCI Global Min Vol Factor ETF (ACWV) stake by 1.3% in Q1 2026, buying an estimated $3.92M and bringing the position to 2,438,432 shares worth $291M. The position accounts for 8.3% of the portfolio, ranked #4.
Aspiriant LLC first reported a position in ACWV in Q3 2015 and has held it in 43 quarters since. The position peaked at $292M in Q4 2021. 311 funds tracked by Wall St. Rank hold ACWV as of Q1 2026.
- Aspiriant LLC held 2,438,432 shares of iShares MSCI Global Min Vol Factor ETF worth $291M as of Q1 2026.
- Aspiriant LLC bought 32,332 iShares MSCI Global Min Vol Factor ETF shares in Q1 2026, an estimated $3.92M.
- iShares MSCI Global Min Vol Factor ETF made up 8.3% of Aspiriant LLC's portfolio in Q1 2026, its #4 holding.
- Aspiriant LLC first reported a position in iShares MSCI Global Min Vol Factor ETF in Q3 2015 and has held it in 43 quarters since.
- Aspiriant LLC's iShares MSCI Global Min Vol Factor ETF position peaked at $292M in Q4 2021.
- 311 funds tracked by Wall St. Rank held iShares MSCI Global Min Vol Factor ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.